DMT and a Shared Alien Universe?

As The New Republic reports, the Colorado-based psychedelics startup Medicinal Mindfulness is currently seeking approval from the Food and Drug Administration to study what it's calling DMTx, an extended-state, intravenous drip version of DMT that will induce in users trips far longer than the roughly five-to-ten minute experiences the drug typically provides.

DMT carries with it a ton of intriguing qualities, including that studies suggest our brains produce the drug naturally and that those who have taken it often experience variations on the same theme: entering what seems to be another plane or dimension replete with its own ethereal beings, sometimes referred to as "machine elves," who are there to welcome them.

Read more

Psilocybin and Bipolar Disorder

Researchers collected survey data from over 500 people with bipolar disorder about their experiences using psilocybin, the results of which were published in a previous paper.

One third of those participants said they experienced “new or increasing symptoms” following psilocybin use, but overall, participants indicated that they believed psilocybin was not harmful.

Read more